1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study

Lignende værker

• Does Once-Daily Raltegravir Have Any Role in the Antiretroviral Treatment?
  af: Gutierrez-Valencia, Alicia, et al.
  Udgivet: (2015)
• Population Pharmacokinetic Analysis of Raltegravir Pediatric Formulations in HIV-infected Children 4 weeks to 18 years of age
  af: Rizk, Matthew L., et al.
  Udgivet: (2015)
• 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects
  af: Krishna, Rajesh, et al.
  Udgivet: (2014)
• Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial
  af: Nachman, Sharon, et al.
  Udgivet: (2018)
• 936 Tolerability, Adherence and Completion of New Occupational HIV Post-Exposure Prophylaxis Regimens (Tenofovir + Emtricitabine and Raltegravir)
  af: Bock, Izona, et al.
  Udgivet: (2014)